Market Overview:
The global oligonucleotide pool library market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for oligonucleotide pool libraries in various applications such as target capture, CRISPR/Cas9 designs, gene synthesis, library preparation and others. Additionally, the growing demand for nucleic acids from biotechnology and pharmaceutical companies is also contributing to the growth of this market. However, stringent regulatory norms related to nucleic acids may hamper the growth of this market in some regions.
Product Definition:
An oligonucleotide pool library is a collection of DNA or RNA molecules, each of which is composed of a set of oligonucleotides. Oligonucleotide pool libraries are used for screening for genes or nucleic acid sequences that are associated with a particular phenotype.
12K Different Oligo per Pools:
12K Different Oligo per Pools, also known as 12KDP or 12 K oligos, is an expression library designed for high-throughput screening of novel small molecule compounds. It was created by Life Technologies Corporation and is marketed by Thermo Fisher Scientific. The library allows the synthesis of a broad range of oligonucleotides with different sequences for every purpose including target identification and validation.
90K Different Oligo per Pools:
90K Different Oligo per Pools is a new technology that allows the synthesis of different oligos with unique 3' and 5' ends. It offers an efficient solution for the combinatorial generation of high-quality, fully degenerate oligos with uniformity in every lot.
The 90K Different Oligo per Pools system has been designed to provide maximum efficiency and reproducibility at a lower price than other available technologies.
Application Insights:
Target capture applications accounted for the largest revenue share in 2017. This is due to its rising adoption in various research studies and clinical trials. Target capture oligonucleotides are used as a component of an oligonucleotide probe that specifically binds to a target DNA sequence, which enables researchers to identify the location of specific genes with high specificity and sensitivity during research studies or clinical diagnostics.
The other application segment includes use of oligonucleotides for gene synthesis, library preparation, or any other application that does not fall under target capture or CRISPR/Cas9 designs. The increasing number of companies focusing on new product development has led to increased usage in various applications across several therapeutic areas such as anti-viral drugs & vaccines, anti-cancer drugs & vaccines, antibiotics etc., thereby driving the global market growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a substantial number of CRISPR/Cas9 target discovery and research institutes, which have been collaborating with companies for pooling strategies. The U.S.-based company Intellia is one such company that has developed an innovative platform for oligonucleotide synthesis and services based on this technology.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing investments by governments in emerging economies along with rising awareness about genome editing technologies among researchers from Asian countries. China, Japan, Singapore, South Korea are some of the Asian countries having well-developed research infrastructure pertaining to genome editing technologies including CRISPR/Cas9 system as well as synthetic library methodsologies. These factors are anticipated to boost regional growth during the forecast period from 2018 to 2030 (Ref.).
Growth Factors:
- Increasing demand for personalized medicines
- Growing number of research and development activities in the field of nucleic acids and oligonucleotides
- Rising prevalence of genetic disorders
- Technological advancements in the field of nucleic acid sequencing
- Growing investments by pharmaceutical and biotechnology companies
Scope Of The Report
Report Attributes
Report Details
Report Title
Oligonucleotide Pool Library Market Research Report
By Type
12K Different Oligo per Pools, 90K Different Oligo per Pools, Other
By Application
Target Capture, CRISPR/Cas9 Designs, Gene Synthesis, Library Preparation, Other
By Companies
Agilent, Eurogentec S.A, Sigmaaldrich, Illumnia, L.G.C Biosearch Technologies, Eurofins Genomics, Roche NimbleGe, Integrated DNA Technologies, Nitto Denko Avecia Inc, General Biosystems, MYcroarray, Twist Bioscience, CustomArray, LC Sciences, Creative Biogene
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Oligonucleotide Pool Library Market Report Segments:
The global Oligonucleotide Pool Library market is segmented on the basis of:
Types
12K Different Oligo per Pools, 90K Different Oligo per Pools, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Target Capture, CRISPR/Cas9 Designs, Gene Synthesis, Library Preparation, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent
- Eurogentec S.A
- Sigmaaldrich
- Illumnia
- L.G.C Biosearch Technologies
- Eurofins Genomics
- Roche NimbleGe
- Integrated DNA Technologies
- Nitto Denko Avecia Inc
- General Biosystems
- MYcroarray
- Twist Bioscience
- CustomArray
- LC Sciences
- Creative Biogene
Highlights of The Oligonucleotide Pool Library Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 12K Different Oligo per Pools
- 90K Different Oligo per Pools
- Other
- By Application:
- Target Capture
- CRISPR/Cas9 Designs
- Gene Synthesis
- Library Preparation
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oligonucleotide Pool Library Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An oligonucleotide pool library is a collection of oligonucleotides that are synthesized and screened for specific target sequences.
Some of the key players operating in the oligonucleotide pool library market are Agilent, Eurogentec S.A, Sigmaaldrich, Illumnia, L.G.C Biosearch Technologies, Eurofins Genomics, Roche NimbleGe, Integrated DNA Technologies, Nitto Denko Avecia Inc, General Biosystems, MYcroarray, Twist Bioscience, CustomArray, LC Sciences, Creative Biogene.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oligonucleotide Pool Library Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oligonucleotide Pool Library Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oligonucleotide Pool Library Market - Supply Chain
4.5. Global Oligonucleotide Pool Library Market Forecast
4.5.1. Oligonucleotide Pool Library Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oligonucleotide Pool Library Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oligonucleotide Pool Library Market Absolute $ Opportunity
5. Global Oligonucleotide Pool Library Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oligonucleotide Pool Library Market Size and Volume Forecast by Type
5.3.1. 12K Different Oligo per Pools
5.3.2. 90K Different Oligo per Pools
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oligonucleotide Pool Library Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oligonucleotide Pool Library Market Size and Volume Forecast by Application
6.3.1. Target Capture
6.3.2. CRISPR/Cas9 Designs
6.3.3. Gene Synthesis
6.3.4. Library Preparation
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oligonucleotide Pool Library Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oligonucleotide Pool Library Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oligonucleotide Pool Library Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oligonucleotide Pool Library Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oligonucleotide Pool Library Demand Share Forecast, 2019-2026
9. North America Oligonucleotide Pool Library Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oligonucleotide Pool Library Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oligonucleotide Pool Library Market Size and Volume Forecast by Application
9.4.1. Target Capture
9.4.2. CRISPR/Cas9 Designs
9.4.3. Gene Synthesis
9.4.4. Library Preparation
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oligonucleotide Pool Library Market Size and Volume Forecast by Type
9.7.1. 12K Different Oligo per Pools
9.7.2. 90K Different Oligo per Pools
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oligonucleotide Pool Library Demand Share Forecast, 2019-2026
10. Latin America Oligonucleotide Pool Library Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oligonucleotide Pool Library Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oligonucleotide Pool Library Market Size and Volume Forecast by Application
10.4.1. Target Capture
10.4.2. CRISPR/Cas9 Designs
10.4.3. Gene Synthesis
10.4.4. Library Preparation
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oligonucleotide Pool Library Market Size and Volume Forecast by Type
10.7.1. 12K Different Oligo per Pools
10.7.2. 90K Different Oligo per Pools
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oligonucleotide Pool Library Demand Share Forecast, 2019-2026
11. Europe Oligonucleotide Pool Library Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oligonucleotide Pool Library Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oligonucleotide Pool Library Market Size and Volume Forecast by Application
11.4.1. Target Capture
11.4.2. CRISPR/Cas9 Designs
11.4.3. Gene Synthesis
11.4.4. Library Preparation
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oligonucleotide Pool Library Market Size and Volume Forecast by Type
11.7.1. 12K Different Oligo per Pools
11.7.2. 90K Diferent Oligo per Pools
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oligonucleotide Pool Library Demand Share, 2019-2026
12. Asia Pacific Oligonucleotide Pool Library Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oligonucleotide Pool Library Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oligonucleotide Pool Library Market Size and Volume Forecast by Application
12.4.1. Target Capture
12.4.2. CRISPR/Cas9 Designs
12.4.3. Gene Synthesis
12.4.4. Library Preparation
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oligonucleotide Pool Library Market Size and Volume Forecast by Type
12.7.1. 12K Different Oligo per Pools
12.7.2. 90K Different Oligo per Pools
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oligonucleotide Pool Library Demand Share, 2019-2026
13. Middle East & Africa Oligonucleotide Pool Library Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oligonucleotide Pool Library Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oligonucleotide Pool Library Market Size and Volume Forecast by Application
13.4.1. Target Capture
13.4.2. CRISPR/Cas9 Designs
13.4.3. Gene Synthesis
13.4.4. Library Preparation
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oligonucleotide Pool Library Market Size and Volume Forecast by Type
13.7.1. 12K Different Oligo per Pools
13.7.2. 90K Different Oligo per Pools
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oligonucleotide Pool Library Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oligonucleotide Pool Library Market: Market Share Analysis
14.2. Oligonucleotide Pool Library Distributors and Customers
14.3. Oligonucleotide Pool Library Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Agilent
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Eurogentec S.A
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sigmaaldrich
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Illumnia
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. L.G.C Biosearch Technologies
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Eurofins Genomics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Roche NimbleGe
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Integrated DNA Technologies
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Nitto Denko Avecia Inc
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. General Biosystems
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. MYcroarray
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Twist Bioscience
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. CustomArray
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. LC Sciences
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Creative Biogene
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
